Product Data Sheet

SARS-CoV-2-IN-82

Catalog No. A53495

main product photo
SARS-CoV-2-IN-82 is a selective inhibitor targeting the programmed -1 ribosomal frameshift (PRF) mechanism in SARS-CoV-2. This compound effectively disrupts viral protein translation, thereby hindering the replication of the virus. It is primarily utilized in research applications focused on understanding the mechanisms of SARS-CoV-2 infection and developing antiviral strategies.
Chemical Information
Catalog NumA53495
M. Wt262.35
FormulaC18H18N2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.924058-34-4
Synonyms
SMILESC12=CC=CC=C1N=C(C3=CC=CC=C23)CN4CCCC4
Biological Activity
DescriptionSARS-CoV-2-IN-82 is a selective inhibitor targeting the programmed -1 ribosomal frameshift (PRF) mechanism in SARS-CoV-2. This compound effectively disrupts viral protein translation, thereby hindering the replication of the virus. It is primarily utilized in research applications focused on understanding the mechanisms of SARS-CoV-2 infection and developing antiviral strategies.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.